日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

AXL-SHC1 signaling axis mediates adaptive resistance to HER2-targeted tyrosine kinase inhibitors in HER2-aberrant lung and gastric cancers

AXL-SHC1信号轴介导HER2异常肺癌和胃癌对HER2靶向酪氨酸激酶抑制剂的适应性耐药

期刊:npj Precision Oncology
影响因子:8
doi:10.1038/s41698-026-01385-2
Ishida, Masaki; Yamada, Tadaaki; Katayama, Yuki; Kawachi, Hayato; Sawada, Ryo; Nakamura, Ryota; Hirai, Soichi; Matsui, Yohei; Morimoto, Kenji; Onoi, Keisuke; Nakamura-Sasada, Aosa; Horinaka, Mano; Sakai, Toshiyuki; Sakakida, Tomoki; Doi, Toshifumi; Yasumoto, Kazuo; Goto, Yasuhiro; Furuya, Naoki; Taniguchi, Hirokazu; Ogino, Hirokazu; Takayuki, Nakano; Chihara, Yusuke; Fukuda, Koji; Taniguchi, Hiroaki; Uehara, Hisanori; Yano, Seiji; Tokuda, Shinsaku; Takayama, Koichi
胃癌
肺癌
肿瘤
HER2
肿瘤免疫
信号转导
AXL
SHC1
发表日期：2026
文献求助 收藏

Hydrostatic pressure from basal side promotes cancer proliferation, enhances migration, and alters cell polarity: A model of the effects of interstitial fluid pressure in tumor microenvironment

基底侧静水压力促进癌细胞增殖、增强癌细胞迁移并改变细胞极性：肿瘤微环境中间质液压力效应的模型

期刊:Molecular Biology of the Cell
影响因子:2.7
doi:10.1091/mbc.E25-05-0261
Onoi, Keisuke; Nakamura-Sasada, Aosa; Tokuda, Shinsaku; Fukui, Mototaka; Katayama, Yuki; Kawachi, Hayato; Nishioka, Naoya; Iwasaku, Masahiro; Sakai, Toshiyuki; Furuya, Tatsuo; Ishihara, Shunta; Okada, Satoru; Inoue, Masayoshi; Yamada, Tadaaki; Takayama, Koichi
肿瘤
肿瘤免疫
细胞极性
细胞生物学
肿瘤微环境
发表日期：2026
文献求助 收藏

Chest Wall Reconstruction and Chemotherapy for Infectious Costochondritis Associated with Recurrent Breast Cancer

胸壁重建和化疗治疗与复发性乳腺癌相关的感染性肋软骨炎

期刊:Surgical Case Reports
影响因子:0.7
doi:10.70352/scrj.cr.25-0703
Katayama, Yuki; Sakuragi, Masako; Matsumoto, Mariko; Machinaga, Mitsuki; Ogihara, Kasumi; Fukuda, Takayo; Shiba, Satomi; Kawata, Hirotoshi; Harao, Michiko; Yamaguchi, Hironori
炎症/感染
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy

癌症恶病质对PD-L1肿瘤比例评分≥50%的非小细胞肺癌患者接受帕博利珠单抗单药治疗与免疫检查点抑制剂联合化疗治疗预后的临床影响

期刊:Oncoimmunology
影响因子:6.3
doi:10.1080/2162402X.2024.2442116
Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Kijima, Takashi; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Shimose, Takayuki; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

Lorlatinib in ALK-positive non-small cell lung cancer: final survival data that reshape the therapeutic landscape

劳拉替尼治疗ALK阳性非小细胞肺癌：最终生存数据重塑了治疗格局

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-466
Katayama, Yuki
肺癌
肿瘤
肿瘤免疫
ALK
细胞生物学
发表日期：2025
文献求助 收藏

Impact of mutant protein expression on clinical outcomes in patients with EGFR L858R-mutated non-small cell lung cancer

突变蛋白表达对EGFR L858R突变型非小细胞肺癌患者临床结局的影响

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-2025-126
Nakamura, Ryota; Yamada, Tadaaki; Morimoto, Kenji; Yoshimura, Akihiro; Shiotsu, Shinsuke; Motono, Nozomu; Uramoto, Hidetaka; Imabayashi, Tatsuya; Takemura, Yoshizumi; Katayama, Yuki; Nishioka, Naoya; Iwasaku, Masahiro; Tokuda, Shinsaku; Okada, Satoru; Shimomura, Masanori; Inoue, Masayoshi; Tanaka, Noriyuki; Miyagawa-Hayashino, Aya; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Estimating the Optimal COVID-19 Booster Timing Using Surrogate Correlates of Protection: A Longitudinal Antibody Study in Naïve and Previously Infected Individuals

利用保护性替代指标估算 COVID-19 加强免疫的最佳时机：一项针对初次感染者和既往感染者的纵向抗体研究

期刊:Pathogens
影响因子:3.3
doi:10.3390/pathogens14111138
Fujiya, Yoshihiro; Kobayashi, Ryo; Tanaka, Makito; Suzuki, Ema; Hinotsu, Shiro; Nakae, Mami; Sato, Yuki; Katayama, Yuki; Saeki, Masachika; Yakuwa, Yuki; Nirasawa, Shinya; Endoh, Akemi; Kuronuma, Koji; Takahashi, Satoshi
炎症/感染
免疫/内分泌
发表日期：2025
文献求助 收藏

Prognostic impact of clinical factors for immune checkpoint inhibitor with or without chemotherapy in older patients with non-small cell lung cancer and PD-L1 TPS ≥ 50

临床因素对老年非小细胞肺癌患者（PD-L1 TPS ≥ 50）接受免疫检查点抑制剂联合或不联合化疗的预后影响

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1348034
Takei, Shota; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Katayama, Yuki; Nishioka, Naoya; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
肺癌
免疫/内分泌
PD-L1
肿瘤
细胞生物学
肿瘤免疫
发表日期：2024
文献求助 收藏

Unraveling the influence of TTF-1 expression on immunotherapy outcomes in PD-L1-high non-squamous NSCLC: a retrospective multicenter study

揭示TTF-1表达对PD-L1高表达非鳞状非小细胞肺癌免疫治疗疗效的影响：一项回顾性多中心研究

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2024.1399889
Nishioka, Naoya; Kawachi, Hayato; Yamada, Tadaaki; Tamiya, Motohiro; Negi, Yoshiki; Goto, Yasuhiro; Nakao, Akira; Shiotsu, Shinsuke; Tanimura, Keiko; Takeda, Takayuki; Okada, Asuka; Harada, Taishi; Date, Koji; Chihara, Yusuke; Hasegawa, Isao; Tamiya, Nobuyo; Masui, Taiki; Sai, Natsuki; Ishida, Masaki; Katayama, Yuki; Morimoto, Kenji; Iwasaku, Masahiro; Tokuda, Shinsaku; Kijima, Takashi; Takayama, Koichi
肺癌
肿瘤
肿瘤免疫
PD-L1
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

Effects of Combined Therapeutic Targeting of AXL and ATR on Pleural Mesothelioma Cells.

联合靶向 AXL 和 ATR 对胸膜间皮瘤细胞的影响

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-23-0138
Hirai Soichi, Yamada Tadaaki, Katayama Yuki, Ishida Masaki, Kawachi Hayato, Matsui Yohei, Nakamura Ryota, Morimoto Kenji, Horinaka Mano, Sakai Toshiyuki, Sekido Yoshitaka, Tokuda Shinsaku, Takayama Koichi
细胞生物学
发表日期：2024
文献求助 收藏